
### [MONDO:0011380](http://purl.obolibrary.org/obo/MONDO_0011380)
**Label:** leukoencephalopathy with vanishing white matter

**Subclasses:** [MONDO:0015521](http://purl.obolibrary.org/obo/MONDO_0015521) (juvenile or adult CACH syndrome), [MONDO:0014387](http://purl.obolibrary.org/obo/MONDO_0014387) (leukoencephalopathy, progressive, with ovarian failure), [MONDO:0015520](http://purl.obolibrary.org/obo/MONDO_0015520) (late infantile CACH syndrome), [MONDO:0020506](http://purl.obolibrary.org/obo/MONDO_0020506) (ovarioleukodystrophy), [MONDO:0020507](http://purl.obolibrary.org/obo/MONDO_0020507) (Cree leukoencephalopathy), [MONDO:0015519](http://purl.obolibrary.org/obo/MONDO_0015519) (congenital or early infantile CACH syndrome), 

**Mapped go classes:** [GO:0043039](http://purl.obolibrary.org/obo/GO_0043039) (tRNA aminoacylation), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0006400](http://purl.obolibrary.org/obo/GO_0006400) (tRNA modification), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004812](http://purl.obolibrary.org/obo/GO_0004812) (aminoacyl-tRNA ligase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0004813](http://purl.obolibrary.org/obo/GO_0004813) (alanine-tRNA ligase activity), [GO:0006419](http://purl.obolibrary.org/obo/GO_0006419) (alanyl-tRNA aminoacylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0070143](http://purl.obolibrary.org/obo/GO_0070143) (mitochondrial alanyl-tRNA aminoacylation), [GO:0033108](http://purl.obolibrary.org/obo/GO_0033108) (mitochondrial respiratory chain complex assembly), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), 

**Class expressions from DL-Learner:**

- [GO:0070143](http://purl.obolibrary.org/obo/GO_0070143) (mitochondrial alanyl-tRNA aminoacylation) 66.67%
- [GO:0006419](http://purl.obolibrary.org/obo/GO_0006419) (alanyl-tRNA aminoacylation) 66.67%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 66.67%
- [GO:0004813](http://purl.obolibrary.org/obo/GO_0004813) (alanine-tRNA ligase activity) 66.67%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 66.67%


